Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hims and Hers Health Inc (HIMS) vs Hormel Foods Corp (HRL) Price & Performance

Hims and Hers Health IncTrade
Hormel Foods CorpTrade

Price performance (Past 24H)

Key statistics

Hims and Hers Health Inc vs Hormel Foods Corp — how do they compare? Hims and Hers Health Inc trades at $30.12 (market cap $7.12B), while Hormel Foods Corp trades at $24.25 (market cap $13.37B). The key difference: Hormel Foods Corp is the larger of the two by market cap, and Hormel Foods Corp pays a 4.81% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

HIMSHRL
Market Cap
$7.12B$13.37B
Sector
HealthConsumer Staples
52-Week High
$62.76$29.25
52-Week Low
$14.52$19.74
Enterprise Value
$7.82B$15.37B
Dividend Yield
4.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hims and Hers Health Inc

HIMS stock trades at $30.00, down 5.57% amid mixed Q2 2026 results. Revenue growth remains strong, with a 2026 outlook raised to $3.1B-$3.3B, but profitability is pressured by margin compression and a wider-than-expected quarterly loss. Technical indicators are neutral to bearish, with the price near key support at $30. Recent news highlights an FTC investigation and class-action lawsuits as headwinds.

The investment outlook is cautious. Growth prospects from subscriber gains and AI integration are offset by significant margin challenges and regulatory risks. Analyst consensus is a Hold with a $33.00 price target, suggesting limited near-term upside amid profitability concerns and negative free cash flow trends.

Hormel Foods Corp

Hormel Foods (HRL) trades at $24.23, down 1.92% over 24 hours, amid a bearish technical signal. The stock shows consistent earnings beats with Q1 2026 EPS of $0.40 surpassing the $0.3544 estimate. Revenue for 2025 was $12.11B, though net income margin compressed to 3.82%. Recent corporate developments include the appointment of John Ghingo as CEO and the sale of its CERATTI business in Brazil.

HRL presents a mixed outlook with a defensive profile as a consumer staple, supported by a 4.6% dividend yield. However, margin pressures and a bearish technical trend pose near-term risks. The consensus price target of $26.33 implies modest upside, but investor sentiment remains cautious given high hold ratings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS

About Hormel Foods Corp

Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.

Read more on HRL